Cargando…

A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant

A unique case of primary refractory FLT3-itd mutated acute myeloid leukemia in an elderly patient, who achieved completed morphological remission, and FLT3-itd negativity, following 9 cycles of azacitadine in combination with escalating doses of donor lymphocyte infusions following relapse 18 months...

Descripción completa

Detalles Bibliográficos
Autores principales: Horgan, Claire, Kanellopoulos, Alexandros, Paneesha, Shankara, Kishore, Bhuvan, Lovell, Richard, Nikolousis, Emmanouil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397996/
https://www.ncbi.nlm.nih.gov/pubmed/30915202
http://dx.doi.org/10.4081/hr.2019.7800
_version_ 1783399504050913280
author Horgan, Claire
Kanellopoulos, Alexandros
Paneesha, Shankara
Kishore, Bhuvan
Lovell, Richard
Nikolousis, Emmanouil
author_facet Horgan, Claire
Kanellopoulos, Alexandros
Paneesha, Shankara
Kishore, Bhuvan
Lovell, Richard
Nikolousis, Emmanouil
author_sort Horgan, Claire
collection PubMed
description A unique case of primary refractory FLT3-itd mutated acute myeloid leukemia in an elderly patient, who achieved completed morphological remission, and FLT3-itd negativity, following 9 cycles of azacitadine in combination with escalating doses of donor lymphocyte infusions following relapse 18 months post reduced intensity HLAA mismatch Campath conditioning allogeneic stem cell transplant.
format Online
Article
Text
id pubmed-6397996
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-63979962019-03-26 A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant Horgan, Claire Kanellopoulos, Alexandros Paneesha, Shankara Kishore, Bhuvan Lovell, Richard Nikolousis, Emmanouil Hematol Rep Case Report A unique case of primary refractory FLT3-itd mutated acute myeloid leukemia in an elderly patient, who achieved completed morphological remission, and FLT3-itd negativity, following 9 cycles of azacitadine in combination with escalating doses of donor lymphocyte infusions following relapse 18 months post reduced intensity HLAA mismatch Campath conditioning allogeneic stem cell transplant. PAGEPress Publications, Pavia, Italy 2019-02-25 /pmc/articles/PMC6397996/ /pubmed/30915202 http://dx.doi.org/10.4081/hr.2019.7800 Text en ©Copyright C. Horgan et al., 2019 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Horgan, Claire
Kanellopoulos, Alexandros
Paneesha, Shankara
Kishore, Bhuvan
Lovell, Richard
Nikolousis, Emmanouil
A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
title A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
title_full A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
title_fullStr A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
title_full_unstemmed A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
title_short A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
title_sort unique case of durable complete remission after salvage with azacitidine and dli for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397996/
https://www.ncbi.nlm.nih.gov/pubmed/30915202
http://dx.doi.org/10.4081/hr.2019.7800
work_keys_str_mv AT horganclaire auniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT kanellopoulosalexandros auniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT paneeshashankara auniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT kishorebhuvan auniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT lovellrichard auniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT nikolousisemmanouil auniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT horganclaire uniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT kanellopoulosalexandros uniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT paneeshashankara uniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT kishorebhuvan uniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT lovellrichard uniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant
AT nikolousisemmanouil uniquecaseofdurablecompleteremissionaftersalvagewithazacitidineanddliforhighriskflt3positiveacutemyeloidleukemiafollowingrelapse18monthspostallogeneicstemcelltransplant